Published in Circ Shock on January 01, 1987
Occult hypoperfusion is associated with increased mortality in hemodynamically stable, high-risk, surgical patients. Crit Care (2004) 1.89
Effect of N-acetylcysteine and fructose-1,6-bisphosphate in the treatment of experimental sepsis. Inflammation (2011) 0.82
The haemodynamics of septic shock. Intensive Care Med (1990) 0.78
Lactate concentration gradient from right atrium to pulmonary artery: a commentary. Crit Care (2005) 0.77
Muscle lactate concentration during experimental hemorrhagic shock. J Anesth (1998) 0.75
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med (1996) 35.00
Increased plasma levels of interleukin-6 in sepsis. Blood (1989) 3.92
Carpal tunnel syndrome: prevalence in the general population. J Clin Epidemiol (1992) 3.80
Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. Br J Gen Pract (2003) 3.56
Cervical lymph node metastasis: assessment of radiologic criteria. Radiology (1990) 3.24
A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci (1993) 3.16
Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet (1998) 2.84
Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet (1992) 2.41
Hypernatremia in the intensive care unit: an indicator of quality of care? Crit Care Med (1999) 2.33
Effect of feedback on test ordering behaviour of general practitioners. BMJ (1992) 2.24
Efficacy of provocative tests for diagnosis of carpal tunnel syndrome. Lancet (1990) 2.15
Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis. Intensive Care Med (1998) 2.12
[Glucose intolerance in elderly persons in The Netherlands; the Twello Study]. Ned Tijdschr Geneeskd (1995) 2.07
The granularity of medical narratives and its effect on the speed and completeness of information retrieval. J Am Med Inform Assoc (1998) 2.03
von Willebrand factor and early diabetic retinopathy: no evidence for a relationship in patients with type 1 (insulin-dependent) diabetes mellitus and normal urinary albumin excretion. Diabetologia (1992) 2.01
Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer (1994) 1.98
Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun (1992) 1.85
Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer (1993) 1.82
Lack of effectiveness of bed rest for sciatica. N Engl J Med (1999) 1.82
Risk factors for carpal tunnel syndrome. Am J Epidemiol (1990) 1.75
Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate. Eur Respir J (2006) 1.74
A new validated endurance performance test. Med Sci Sports Exerc (1996) 1.68
Do metastases in vertebrae begin in the body or the pedicles? Imaging study in 45 patients. AJR Am J Roentgenol (1992) 1.68
Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. J Lab Clin Med (1992) 1.65
Transvascular transport of 67Ga in the lungs after cardiopulmonary bypass surgery. Chest (1993) 1.64
C1-esterase inhibitor substitution in sepsis. Lancet (1992) 1.61
Prediction of mortality in febrile medical patients: How useful are systemic inflammatory response syndrome and sepsis criteria? Chest (1998) 1.61
Role of cytokines in sepsis. Adv Immunol (1997) 1.60
Anal dynamic graciloplasty in the treatment of intractable fecal incontinence. N Engl J Med (1995) 1.59
Continuous cardiac output in septic shock by simulating a model of the aortic input impedance: a comparison with bolus injection thermodilution. Anesthesiology (1999) 1.57
The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol (1996) 1.56
Outcome of ICU treatment in invasive aspergillosis. Intensive Care Med (1996) 1.52
Antithrombin III in patients with severe sepsis: a pharmacokinetic study. Intensive Care Med (2000) 1.49
Acute lung injury after aortic surgery: the relation between lung and leg microvascular permeability to 111indium-labelled transferrin and circulating mediators. Thorax (1997) 1.48
Cardiac tamponade from misplaced central venous line in pericardiophrenic vein. Arch Intern Med (1988) 1.48
Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood (1995) 1.47
C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. Intensive Care Med (1993) 1.45
Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit Care Med (1990) 1.43
Acute renal failure in the medical intensive care unit: predisposing, complicating factors and outcome. Nephron (1991) 1.41
Predicting outcome after cardiac surgery: comparison of global haemodynamic and tonometric variables. Br J Anaesth (1999) 1.41
Reliable gastric tonometry after coronary artery surgery: need for acid secretion suppression despite transient failure of acid secretion. Intensive Care Med (1998) 1.38
Incidence of and risk factors for asymptomatic peripheral arterial occlusive disease: a longitudinal study. Am J Epidemiol (2001) 1.37
Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain (1993) 1.35
Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am J Med (1989) 1.34
Randomised controlled trial of routine individual feedback to improve rationality and reduce numbers of test requests. Lancet (1995) 1.30
Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation. Infect Immun (2000) 1.30
Fitting a routine health-care activity into a randomized trial: an experiment possible without informed consent? J Clin Epidemiol (1997) 1.27
Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-alpha1-antitrypsin, and lactoferrin compared with clinical variables. Clin Infect Dis (1999) 1.26
Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med (2001) 1.26
Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis. Ann Intern Med (1994) 1.25
Essential fatty acid composition of plasma phospholipids and birth weight: a study in term neonates. Am J Clin Nutr (2001) 1.24
Proteolytic inactivation of plasma C1- inhibitor in sepsis. J Clin Invest (1989) 1.22
Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status. Br J Nutr (1995) 1.21
Peripheral vascular resistance in septic shock: its relation to outcome. Intensive Care Med (1988) 1.20
The diagnostic value of the measurement of the ankle-brachial systolic pressure index in primary health care. J Clin Epidemiol (1996) 1.19
Interobserver variability in the use of APACHE II scores. Lancet (1999) 1.19
Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. J Clin Endocrinol Metab (2001) 1.18
Effects of routine individual feedback over nine years on general practitioners' requests for tests. BMJ (1996) 1.18
Inflammatory mediators in dengue virus infection in children: interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2. Am J Trop Med Hyg (2001) 1.16
Gastrointestinal luminal PCO2 tonometry: an update on physiology, methodology and clinical applications. Br J Anaesth (2000) 1.15
Local corticosteroid injection versus Cyriax-type physiotherapy for tennis elbow. J Bone Joint Surg Br (1996) 1.15
Incidence of medically treated burns in The Netherlands. Burns (1991) 1.15
Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis. Blood (1988) 1.15
Cow's milk protein intolerance in infants under 1 year of age: a prospective epidemiological study. Eur J Pediatr (1993) 1.11
Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor. Am J Cardiol (1993) 1.10
Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease. The Limburg PAOD Study. Peripheral Arterial Occlusive Disease. Scand J Prim Health Care (1998) 1.10
Accuracy and reliability of APACHE II scoring in two intensive care units Problems and pitfalls in the use of APACHE II and suggestions for improvement. Anaesthesia (2001) 1.10
Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg (1995) 1.09
Long-term follow-up after cancer rehabilitation using high-intensity resistance training: persistent improvement of physical performance and quality of life. Br J Cancer (2008) 1.09
Risk factors for multiple organ system failure and death in critically injured patients. Surgery (1993) 1.08
Pattern recognition in magnetic resonance imaging of white matter disorders in children and young adults. Neuroradiology (1991) 1.07
[Limited changes in prescription of third-generation oral contraceptives after reports on elevated thrombosis risk and subsequent professional guidelines]. Ned Tijdschr Geneeskd (2000) 1.07
[Corticosteroid administration for critically ill patients]. Ned Tijdschr Geneeskd (2001) 1.07
Diagnostic value of signs and symptoms associated with peripheral arterial occlusive disease seen in general practice: a multivariable approach. Med Decis Making (1997) 1.07
Hemodynamic determinants of mortality in human septic shock. Surgery (1986) 1.07
Exercise induces gastric ischemia in healthy volunteers: a tonometry study. J Appl Physiol (1985) (2001) 1.06
Frequencies of lipopolysaccharide core types in Escherichia coli strains from bacteraemic patients. Microbiology (1994) 1.06
The influence of experience on the reproducibility of the ankle-brachial systolic pressure ratio in peripheral arterial occlusive disease. Eur J Vasc Endovasc Surg (1999) 1.06
Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity. AJR Am J Roentgenol (1992) 1.05
Long-term growth of children with congenital heart disease: a retrospective study. Acta Paediatr (1998) 1.05
Biventricular performance during volume loading in patients with early septic shock, with emphasis on the right ventricle: a combined hemodynamic and radionuclide study. Am Heart J (1988) 1.04
Plasma lipid peroxides and antioxidants in human septic shock. Intensive Care Med (1991) 1.04
Factors predicting differences among general practitioners in test ordering behaviour and in the response to feedback on test requests. Fam Pract (1996) 1.03
Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock. Semin Thromb Hemost (1998) 1.03
Methylene blue increases myocardial function in septic shock. Crit Care Med (1995) 1.03
Architectural and nuclear morphometrical features together are more important prognosticators in endometrial hyperplasias than nuclear morphometrical features alone. J Pathol (1988) 1.03
International sepsis trial (INTERSEPT): role and impact of a clinical evaluation committee. Crit Care Med (1996) 1.02
Relative adrenal failure in intensive care: an identifiable problem requiring treatment? Best Pract Res Clin Endocrinol Metab (2001) 1.01